Literature DB >> 34245775

Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases.

Ying Chen1, Hao Wang2, Wen-Zhi Wang3, Dong Wang3, Keith Skaggs4, Han-Ting Zhang5.   

Abstract

Phosphodiesterase 7 (PDE7), one of the 11 phosphodiesterase (PDE) families, specifically hydrolyzes cyclic 3', 5'-adenosine monophosphate (cAMP). PDE7 is involved in many important functional processes in physiology and pathology by regulating intracellular cAMP signaling. Studies have demonstrated that PDE7 is widely expressed in the central nervous system (CNS) and potentially related to pathogenesis of many CNS diseases. Here, we summarized the classification and distribution of PDE7 in the brain and its functional roles in the mediation of CNS diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), multiple sclerosis (MS), and schizophrenia. It is expected that the findings collected here will not only lead to a better understanding of the mechanisms by which PDE7 mediates CNS function and diseases, but also aid in the development of novel drugs targeting PDE7 for treatment of CNS diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (AD); (PD); (PDE7); (cAMP); Alzheimer's disease; PDE7 inhibitor;Parkinson's disease; Phosphodiesterase 7; yclic adenosine monophosphate

Mesh:

Substances:

Year:  2021        PMID: 34245775     DOI: 10.1016/j.neuropharm.2021.108694

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  2 in total

Review 1.  Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders.

Authors:  Heena Khan; Chanchal Tiwari; Amarjot Kaur Grewal; Thakur Gurjeet Singh; Simran Chauhan; Gaber El-Saber Batiha
Journal:  Inflammopharmacology       Date:  2022-10-22       Impact factor: 5.093

Review 2.  Pros and Cons of Pharmacological Manipulation of cGMP-PDEs in the Prevention and Treatment of Breast Cancer.

Authors:  Patrizia Di Iorio; Maurizio Ronci; Patricia Giuliani; Francesco Caciagli; Renata Ciccarelli; Vanni Caruso; Sarah Beggiato; Mariachiara Zuccarini
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.